Developing a validated methodology for identifying clozapine treatment periods in electronic health records
Abstract Background Clozapine is the only recommended antipsychotic medication for individuals diagnosed with treatment-resistant schizophrenia. Unfortunately, its wider use is hindered by several possible adverse effects, some of which are rare but potentially life threatening. As such, there is a...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2024-08-01
|
| Reeks: | BMC Psychiatry |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12888-024-06022-5 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|